Tarsus Pharmaceuticals Inc. (TARS)
Market Open
26 Oct, 06:09 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
70. 34
+2.14
+3.1452%
$
3.19B Market Cap
- P/E Ratio
- Div Yield
11,709 Volume
-4.18 Eps
$ 68.2
Previous Close 
Want to track TARS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Tarsus Pharmaceuticals Inc. (TARS) Statistics
Valuation metrics
Market Cap 3.19B
Enterprise value 3.08B
Trailing P/E (ttm) -62.57
Forward P/E -
PEG ratio -0.75
Price/Sales (ttm) 5.26
Price/Book (mrq) 8.54
Enterprise Value/Revenue 5.07
Enterprise Value/EBITDA -87.18
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.13M
Average volume (90 days) 835.43K
Price summary
52-Week low 53.89
52-Week high 91.53
Beta -
50-Day moving average 75.73
200-Day moving average 67.3
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.08%
Operating margin -0.08%
Operational effectiveness
Return on assets -0.08%
Return on equity -0.14%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 13.97
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.07
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 10.36
Total debt (mrq) -
Total Debt/Equity (mrq) 0.26
Current ratio (mrq) 3.2%
Book value per share (mrq) 7.99
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
